Navigation Links
Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
Date:9/16/2008

CAMBRIDGE, Mass., Sept. 16 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced today that Dr. Joseph Kovalchin will make a poster presentation titled "Evidence of Specific T-cell Priming from the First-in-Man Single Ascending Dose Study of Peptide Copolymer PI-2301 for the Treatment of Multiple Sclerosis " on Thursday, September 18th from 3:30 - 5:00 p.m. in Exhibit Hall 220C, at the Palais Des Congres de Montreal, Canada at the World Congress on Treatment and Research in Multiple Sclerosis. The Congress is expected to attract over 3,500 participants from around the globe -- clinicians, clinical researchers, and basic scientists. This will be the largest single gathering of MS clinicians and researchers in 2008.

PI-2301 is currently in a Phase Ib multiple-ascending dose, double-blind, placebo-controlled randomized study in subjects with multiple sclerosis. Following establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009.

PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (Teva Pharmaceuticals). PI-2301 has been designed to be more efficacious and more convenient (weekly versus daily dosing) than Copaxone for the treatment of multiple sclerosis. PI-2301 works through immune modulation by enhancing the regulatory response of the immune system and thereby controlling the pathogenic autoimmune response observed in some diseases. In a Phase I single ascending dose, double blind placebo controlled randomized study, all doses of PI-2301 were safe and well tolerated, and no serious adverse events were observed. Pharmacodynamic assays demonstrated evidence of immune exposure consistent with the pharmacologic mechanism of action for PI-2301, and dose-dependent pharmacokinetics was observed.

PI-2301 has been optimized using P
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Peptimmune Announces First Close of Series D Private Financing
2. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
3. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
4. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
5. Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
8. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
10. Volcano Presentation at Thomas Weisel Conference to Be Webcast
11. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , 17 de septiembre de 2014 ... compañía"), principal proveedor mundial de soluciones logísticas ... ciencias de la vida, anunció hoy la ... logística global con sede en Rótterdam, Países ... de clientes Europa en rápido crecimiento. Según ...
(Date:9/17/2014)... Cary, N.C. (PRWEB) September 17, 2014 ... solutions that advances science and healthcare, has renewed its ... term. , As part of the agreement, Personify will ... with a sustained emphasis on recruitment analytics, including time-to-fill, ... decision to renew our agreement with Personify was based ...
(Date:9/17/2014)... Escape Alert, LLC . filed international patents for ... owners if their pet has escaped and enable them to track ... the pet’s body. This is the first implantable microchip with ... around for many years, they are passive until read by scanners, ... pet’s location or alert the owner that the pet has escaped. ...
(Date:9/17/2014)... , September 17, 2014 ... mode of action from a truly novel ... MGB Biopharma, a biopharmaceutical company ... announces today that it has secured £4.0m ... lead antibacterial, MGB-BP-3, against a range of ...
Breaking Biology Technology:Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 2Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7
... and STATE COLLEGE, Pennsylvania, May 9, 2012 ... and SoftGenetics announced today that the two firms ... provide users of 454 Sequencing Systems the broad ... by SoftGenetics NextGENe® software. NextGENe® software ...
... 2012 Phalanx Biotech Group, a global genomic ... of manufacturing and testing for a proprietary targeted ... postnatal detection of microdeletions and microduplications related to ... intellectual delay disorders. Cyto OneArray ® ...
... Nev., May 8, 2012 PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, is scheduled to ... http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ) Eleventh Annual JMP Securities Research ... Francisco, CA Goldman Sachs 33rd Annual Global ...
Cached Biology Technology:Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 2Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 3Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray 2
(Date:9/17/2014)... and MSSA could be curbed by coating hospital ... surface of shark skin, according to research published ... and Infection Control . , The study modelled ... human disease bacteria through touching, sneezes or spillages. ... ridges formulated to resemble shark skin. The study ...
(Date:9/16/2014)... Columbia Center for Children,s Environmental Health at the Mailman ... an association between childhood asthma and prenatal exposure to ... products. Results appear online in the journal Environmental ... exposed during pregnancy to higher levels of the chemicals, ... 72 percent and 78 percent increase in risk of ...
(Date:9/16/2014)... of severe maternal morbidity amongst women in Australia ... new study published today (17 September) in ... . , Australians generally enjoy high standards of ... disparities exist, in particular between indigenous and non ... explore the independent impact of socioeconomic position on ...
Breaking Biology News(10 mins):Sharks' skin has teeth in the fight against hospital superbugs 2Phthalates heighten risk for childhood asthma 2Phthalates heighten risk for childhood asthma 3New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3
... (BUSM) and Veterans Affairs (VA) Boston Healthcare System have identified ... findings, published online in Molecular Psychiatry , indicate that ... cells from the damaging effects of stress may also be ... reports the first positive results of a genome-wide association study ...
... A top national award for promising research scientists ... assistant professor of biology at Rutgers UniversityCamden. Yakoby ... Science Foundation. The five-year, $686,544 award, which is ... of the project, supports the RutgersCamden researcher,s project "Dynamics ...
... for plants but also for all living organisms. In ... growing shortage of this essential mineral, and the price ... therefore high time to start looking for alternatives. This ... replaced by any other substance. But researchers at the ...
Cached Biology News:BUSM/VA Boston Healthcare System investigators identify new gene linked to PTSD 2Rutgers-Camden genetics researcher receives NSF CAREER Award 2Using wastewater as fertilizer 2Using wastewater as fertilizer 3
Self Closing Forceps...
... cells right in your 35mm dish ... dish Perfusion Chamber has separate openings ... dampen the fluctuations of the liquid ... prevent bubbles from entering the chamber. ...
... cells (BTI-TN-5B1-4) derived from Trichoplusia ni ... to be capable of expressing significantly ... compared to other insect cells. High ... doubling time as adherent cultures- Quick adaptation ...
... steadylite plus assay system offers ... sensitivity, Designed for batch-processing systems, ... higher density microplates such as ... free, Convenient storage conditions ( ...
Biology Products: